Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
646.00    -4.00 (-0.62%)
Bid:
643.00
Ask:
647.00
Spread: 4.00 (0.622%)
Market Cap: £1.26b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Director/PDMR Shareholding

13 Apr 2006 16:01

Ceres Power Holdings plc13 April 2006 Ceres Power Holdings plc ("the Company") 13 April 2006 Director Dealings The Company announces details of the following exercises of options and warrantsand the sale of the following ordinary shares of 5p each ('Ordinary Shares') bycertain directors of the Company on 12 April 2006: 1. Mr. John Gunn, a non-executive director of the Company, sold 400,000Ordinary Shares at 315p per share. Mr. Gunn retains 85,280 Ordinary Shares inthe Company, representing approximately 0.15 per cent of the Company's issuedshare capital, in addition to 122,500 warrants over Ordinary Shares in theCompany. Mr. Gunn also has beneficial interests in 1,151,550 Ordinary Shares inthe Company in addition to 330,153 warrants over Ordinary Shares in the Company. 2. Mr. Philip Holbeche, Chairman of the Company, exercised 367,640 warrantsover Ordinary Shares in the Company and sold these Ordinary Shares at 315p pershare. Mr. Holbeche retains 716,400 Ordinary Shares in the Company, representingapproximately 1.25 per cent of the Company's issued share capital, together withoptions over 830,000 Ordinary Shares in the Company. 3. Dr. Peter Bance, Chief Executive of the Company, exercised 250,000options over Ordinary Shares in the Company and sold these at 315p per share.Dr. Bance retains 2,267,400 options over Ordinary Shares in the Company. 4. Dr. Andrew Baker, Operations Director of the Company, exercised 150,000options over Ordinary Shares in the Company and sold these at 315p per share.Dr. Baker retains 450,000 options over Ordinary Shares in the Company. The Company was informed on 13 April 2006 that Harry Fitzgibbons, anon-executive director of the Company, on 13 April 2006 sold 10,000 OrdinaryShares in the Company at 315p per share. Mr. Fitzgibbons' total holding in theCompany is now 160,000 Ordinary Shares, representing approximately 0.3% of theCompany's issued share capital. Enquiries: Matt Stride, Company Secretary +44 (0) 1293 400 404Peter Bance, CEO +44 (0) 1293 400 404 Numis Securities Limited +44 (0) 20 7776 1500David Poutney, James Black M Communications +44 (0) 20 7153 1531Lisa Gordon, Patrick D'Ancona, Charlotte Kirkhan This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20264:00 pmRNSHolding(s) in Company
29th May 202610:00 amRNSTotal Voting Rights
14th May 20263:31 pmRNSDirectorate change
14th May 20263:30 pmRNSResult of AGM
8th May 20263:30 pmRNSHolding(s) in Company
8th May 20263:30 pmRNSGrant of Share Options under the Sharesave Scheme
8th May 202610:30 amRNSHolding(s) in Company
6th May 20269:00 amRNSHolding(s) in Company
5th May 202611:15 amRNSHolding(s) in Company
1st May 20261:15 pmRNSDirector/PDMR Shareholding
1st May 202610:00 amRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSDelta Electronics & Centrica partnership
29th Apr 202611:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSChange of Adviser
17th Apr 20262:30 pmRNSGrant of Long Term Incentive Plan (“LTIP”) Awards
15th Apr 202610:30 amRNSCapital markets event
14th Apr 202611:00 amRNSNotice of AGM & Publication of Annual Report
31st Mar 202610:00 amRNSTotal Voting Rights
26th Mar 20267:02 amRNSCeres and Centrica sign a strategic partnership
26th Mar 20267:00 amRNSFinal results for the year ended 31 December 2025
23rd Mar 20267:00 amRNSNotice of Capital Markets Event
9th Mar 202611:00 amRNSHolding(s) in Company
27th Feb 202612:00 pmRNSTotal Voting Rights
24th Feb 20267:00 amRNSNotice of Results
20th Feb 20269:30 amRNSHolding(s) in Company
16th Feb 20261:00 pmRNSHolding(s) in Company
5th Feb 20266:15 pmRNSHolding(s) in Company
4th Feb 202612:00 pmRNSHolding(s) in Company
30th Jan 202610:00 amRNSTotal Voting Rights
9th Jan 20262:00 pmRNSBlock listing Interim Review
8th Jan 20264:45 pmRNSHolding(s) in Company
6th Jan 202612:00 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
18th Dec 20254:30 pmRNSHolding(s) in Company
18th Dec 20254:30 pmRNSHolding(s) in Company
15th Dec 20252:30 pmRNSHolding(s) in Company
28th Nov 202510:00 amRNSTotal Voting Rights
6th Nov 20253:10 pmRNSHolding(s) in Company
5th Nov 20257:00 amRNSWeichai signs manufacturing licence for SOFC power
31st Oct 20254:15 pmRNSHolding(s) in Company
31st Oct 202510:00 amRNSTotal Voting Rights
27th Oct 20256:00 pmRNSAlpha Group International
15th Oct 202510:00 amRNSHolding(s) in Company
7th Oct 20259:30 amRNSHolding(s) in Company
6th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 202511:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.